Navigation Links
Samsung Medison America Welcomes Brian Keith as Sales General Manager, USA
Date:8/31/2011

CYPRESS, Calif., Aug. 31, 2011 /PRNewswire/ -- Samsung Medison America appoints Brian Keith as Sales General Manager, USA to address a growing demand for its expansive line of Ultrasound platforms. Mr. Keith will be responsible for the US sales organization and its management in Samsung Medison America.

Mr. Keith is an industry veteran with over 15 years of medical device sales experience. He has held numerous strategic positions in several medical device companies including General Electric and Abbott Laboratories.

Most recently, Mr. Keith was the US General Manager, Point of Care Ultrasound at GE Healthcare. He managed a team of direct sales, distributors, clinical specialists, and support staff, demonstrating his capable leadership and accomplishing double digit sales growth year after year. Prior to his recent position, Mr. Keith spent 7 years in various sales management positions within GE including Regional Sales Manager, OB/Gyn Ultrasound market segment as well as Ultrasound Account Executive in OB/Gyn and Urology segments.

“Despite the overall stagnation in the industry, Samsung Medison America achieved a significant growth last year. This is a true testament to our commitment in the US market. Brian Keith has proven his leadership skills in various capacities and I am excited to welcome him to our growing team”, said Charles Sung, CEO of Samsung Medison America.

For more information on Samsung Medison America, visit www.samsungmedisonusa.com or visit booth 13 during the International Congress of OB/Gyn meeting between September 18 and September 22, 2011 in Los Angeles, CA.

About Samsung Medison

Samsung Medison is Korea's leading diagnostic ultrasound company. Founded in 1985, the company is now selling cutting-edge medical devices in 110 countries around the world, with some 85% of its sales coming from outside of Korea. The company has attracted global
'/>"/>

SOURCE Samsung Medison America
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Samsung Medison Pledges to Become a World-Class Medical Device Company
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Aspirin Named 8th World Wonder by Majority of Americans
6. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
7. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
8. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... -   The issue: ... tests confirmed it contains two undeclared amphetamine-like drug substances ... distributor, Empire Health Distribution of Terrebonne, Quebec ... across Canada .  Jetfuel Superburn is ... and increased energy. What consumers should ...
(Date:12/24/2014)... N.Y. , Dec. 24, 2014 Kinex ... dosed with KX2-361 at Roswell Park Cancer Institute. ... small molecule drug that has shown potent inhibitory activity ... including those that are resistant to Temozolomide (T98G), the ... glioma. In a well-established brain tumor mouse model, KX2-361 ...
(Date:12/24/2014)... and FARMINGTON, Conn. , Dec. ... MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific ... significant unmet medical need and commercial potential, today ... placement of 2,050,000 shares of its common stock ... of its common stock.  Funds under the management ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
... and Pipeline Analysis, 4th Edition Now Available... -- DALLAS, September 28, 2010 ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
... SCOLR Pharma, Inc. (NYSE AMEX: DDD ... as the Chairman of its Board of Directors.  Johnson ... the Board.   Johnson previously served as ... Under Johnson,s leadership, Matrixx successfully developed and launched the ...
Cached Medicine Technology:Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 2Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 3Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 4Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 5Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 6Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 7Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 8Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 9SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 2SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 3
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Helen ... home in Woodland Hills, California after an 8 year ... away on Christmas Eve evening in her home in ... aggressive metastatic breast cancer. , As ... over forty years, she pioneered and championed many of ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... children with complex chronic illnesses can receive effective, less expensive ... with easy access to a team of dedicated health care ... to become seriously ill and need either hospitalization or a ... an enhanced medical home clinic at the University of Texas ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... Newton, North Carolina (PRWEB) December 25, 2014 ... a North Carolina Retirement Community, recently showed their ... and girls of the Catawba County Parenting Network- ... meal, the 10 children gathered around the largest ... community to open presents purchased by residents of ...
Breaking Medicine News(10 mins):Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Retirement Community Residents Make Impact During Holiday Season 2
... new study looking at how hospitals account for the ... (CA-BSIs) found substantial inconsistencies in the methods used to ... The study, conducted by the National Association ... Unit Focus Group, appears in the October issue of ...
... among postmenopausal women in Canada as their use of ... September 23 in The Journal of the National ... (WHI) trial of more than 16,000 postmenopausal women in ... of combined estrogen and progestin hormone replacement therapy outweighed ...
... THURSDAY, Sept. 23 (HealthDay News) -- Sexual problems are common ... In a study of about 1,000 women treated for breast ... a partner reported sexual difficulties, such as loss of desire ... see a large number of women who tell us this ...
... Researchers at Mount Sinai School of Medicine have found that ... from hospice were nearly five times higher than for patients ... far more likely to use emergency department care and be ... issue of the Journal of Clinical Oncology. Led by ...
... University surgeon, investigators found that women who give birth ... double normal rates despite the fact that vaginal delivery ... lingering, yet often treatable, symptoms following their pelvic fracture ... The study, published in Clinical ...
... Sciences (NIEHS) is awarding $36 million in grants to ... workers involved in hazardous waste operations and transportation, environmental ... training programs can receive annual funding for up to ... region will use the money to continue ongoing safety ...
Cached Medicine News:Health News:Study of bloodstream infections reveals inconsistent surveillance methods and reporting 2Health News:Declining breast cancer incidence in Canada with declining HRT usage 2Health News:Sexual Problems May Arise After Breast Cancer 2Health News:Sexual Problems May Arise After Breast Cancer 3Health News:Patients with cancer who stop hospice care boost health-care costs 2Health News:Study finds high rate of c-sections after pelvic fractures 2Health News:NIEHS to fund $36 million in worker safety training 2Health News:NIEHS to fund $36 million in worker safety training 3
Both versions of the UltraSling II provide immobilization for rotator cuff repairs, capusular shifts, Bankhart repairs, glenohumeral dislocations/subluxation and soft tissue repairs/strains....
Unique V-lock strapping system prevents roll and shifting to provide secure shoulder immobilization...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... Effective spinal bracing is a critical component ... surgical stabilization. The Aspen® Lumbosacral Bracing System™ ... provide a high degree of immobilization, unparalled ... patients . . . even if they ...
Medicine Products: